» Articles » PMID: 15485868

A Novel Strategy for Defining Critical Amino Acid Residues Involved in Protein/glycosaminoglycan Interactions

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Oct 16
PMID 15485868
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of proteins to glycosaminoglycans (GAGs) is the prerequisite for a large number of cellular processes and regulatory events and is associated to many pathologies. However, progress in the understanding of these mechanisms has been hampered by the lack of simple and comprehensive analytical tools for the identification of the structural attributes involved in protein/saccharide interaction. Characterization of GAG binding motifs on proteins has so far relied on site-directed mutagenesis studies, protein sequence mapping using synthetic peptides, molecular modeling, or structural analysis. Here, we report the development of a novel approach for identifying protein residues involved in the binding to heparin, the archetypal member of the GAG family. This method, which uses native proteins, is based on the formation of cross-linked complexes of the protein of interest with heparin beads, the proteolytic digestion of these complexes, and the subsequent identification of the heparin binding containing peptides by N terminus sequencing. Analysis of the CC chemokine regulated on activation, normal T-cell expressed, and secreted (RANTES), the envelope glycoprotein gC from pseudorabies virus and the laminin-5 alpha 3LG4/5 domain validated the techniques and provided novel information on the heparin binding motifs present within these proteins. Our results highlighted this method as a fast and valuable alternative to existing approaches. Application of this technique should greatly contribute to facilitate the structural study of protein/GAG interactions and the understanding of their biological functions.

Citing Articles

Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.

Damen L, Bui T, van Wessel T, Li Y, Straten B, Pampiermole R Glycobiology. 2024; 34(8).

PMID: 38963938 PMC: 11231949. DOI: 10.1093/glycob/cwae046.


Axonal chemokine-like Orion induces astrocyte infiltration and engulfment during mushroom body neuronal remodeling.

Boulanger A, Thinat C, Zuchner S, Fradkin L, Lortat-Jacob H, Dura J Nat Commun. 2021; 12(1):1849.

PMID: 33758182 PMC: 7988174. DOI: 10.1038/s41467-021-22054-x.


A Systems View of the Heparan Sulfate Interactome.

Gomez Toledo A, Sorrentino J, Sandoval D, Malmstrom J, Lewis N, Esko J J Histochem Cytochem. 2021; 69(2):105-119.

PMID: 33494649 PMC: 7841697. DOI: 10.1369/0022155420988661.


Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.

Crijns H, Vanheule V, Proost P Front Immunol. 2020; 11:483.

PMID: 32296423 PMC: 7138053. DOI: 10.3389/fimmu.2020.00483.


Expression and purification of recombinant extracellular sulfatase HSulf-2 allows deciphering of enzyme sub-domain coordinated role for the binding and 6-O-desulfation of heparan sulfate.

Seffouh A, El Masri R, Makshakova O, Gout E, Hassoun Z, Andrieu J Cell Mol Life Sci. 2019; 76(9):1807-1819.

PMID: 30788513 PMC: 11105607. DOI: 10.1007/s00018-019-03027-2.